Post-translational disruption of the ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR)-molecular chaperone complex with geldanamycin stabilizes ΔF508 CFTR in the rabbit reticulocyte lysate

被引:50
作者
Fuller, W [1 ]
Cuthbert, AW [1 ]
机构
[1] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England
关键词
D O I
10.1074/jbc.M006278200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Delta F508 mutation of cystic fibrosis transmembrane conductance regulator (CFTR) is a trafficking mutant, which is retained and degraded in the endoplasmic reticulum by the ubiquitin-proteasome pathway. The mutant protein fails to reach a completely folded conformation that is no longer a substrate for ubiquitination ("stable B"). Wild type protein reaches this state with 25% efficiency. In this study the rabbit reticulocyte lysate with added microsomal membranes has been used to reproduce the post-translational events in the folding of wild type and Delta F508 CFTR. In this system wild type CFTR does not reach the stable B form if the post-translational temperature is 37 degreesC, whereas at 30 degreesC the behavior of both wild type and mutant proteins mimics that observed in the cell. Geldanamycin stabilizes Delta F508 CFTR with respect to ubiquitination only when added post-translationally. The interaction of wild type and mutant CFTR with the molecular chaperones heat shock cognate 70 (hsc70) and heat shock protein 90 (hsp90) has been assessed. Release of wild type protein from hsc70 coincides with the cessation of ubiquitination and formation of stable B. Geldanamycin immediately prevents the binding of hsp90 to Delta F508 CFTR, and after a delay releases it from hsc70. Release of mutant protein from hsc70 also coincides with the formation of stable B Delta F508 CFTR.
引用
收藏
页码:37462 / 37468
页数:7
相关论文
共 43 条
[21]   CONFORMATIONAL MATURATION OF CFTR BUT NOT ITS MUTANT COUNTERPART (DELTA-F508) OCCURS IN THE ENDOPLASMIC-RETICULUM AND REQUIRES ATP [J].
LUKACS, GL ;
MOHAMED, A ;
KARTNER, N ;
CHANG, XB ;
RIORDAN, JR ;
GRINSTEIN, S .
EMBO JOURNAL, 1994, 13 (24) :6076-6086
[22]   CONVERSION OF EPIDERMAL GROWTH-FACTOR (EGF) INTO A STIMULATORY LIGAND FOR A431-CELL GROWTH BY HERBIMYCIN-A BY DECREASING THE LEVEL OF EXPRESSION OF EGF RECEPTOR [J].
MURAKAMI, Y ;
FUKAZAWA, H ;
MIZUNO, S ;
UEHARA, Y .
BIOCHEMICAL JOURNAL, 1994, 301 :57-62
[23]  
PIND S, 1994, J BIOL CHEM, V269, P12784
[24]   Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone [J].
Prodromou, C ;
Roe, SM ;
OBrien, R ;
Ladbury, JE ;
Piper, PW ;
Pearl, LH .
CELL, 1997, 90 (01) :65-75
[25]   EXPRESSION OF CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CORRECTS DEFECTIVE CHLORIDE CHANNEL REGULATION IN CYSTIC-FIBROSIS AIRWAY EPITHELIAL-CELLS [J].
RICH, DP ;
ANDERSON, MP ;
GREGORY, RJ ;
CHENG, SH ;
PAUL, S ;
JEFFERSON, DM ;
MCCANN, JD ;
KLINGER, KW ;
SMITH, AE ;
WELSH, MJ .
NATURE, 1990, 347 (6291) :358-363
[26]  
RIORDAN JR, 1989, SCIENCE, V245, P1066
[27]   Cotranslational ubiquitination of cystic fibrosis transmembrane conductance regulator in vitro [J].
Sato, S ;
Ward, CL ;
Kopito, RR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (13) :7189-7192
[28]   Hsp70 family molecular chaperones and mutant insulin receptor: Differential binding specificities of BiP and Hsp70/Hsc70 determines accumulation or degradation of insulin receptor [J].
Sawa, T ;
Imamura, T ;
Haruta, T ;
Sasaoka, T ;
Ishiki, M ;
Takata, Y ;
Takada, Y ;
Morioka, H ;
Ishihara, H ;
Usui, I ;
Kobayashi, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 218 (02) :449-453
[29]   The Hsp90 complex - A super-chaperone machine as a novel drug target [J].
Scheibel, T ;
Buchner, J .
BIOCHEMICAL PHARMACOLOGY, 1998, 56 (06) :675-682
[30]   Two chaperone sites in Hsp90 differing in substrate specificity and ATP dependence [J].
Scheibel, T ;
Weikl, T ;
Buchner, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) :1495-1499